Physician Awareness of Immune Responses to Polyethylene Glycol‐Drug Conjugates

Antibodies against polyethylene glycol (PEG) can critically jeopardize the efficacy and safety of PEGylated therapeutics. For some PEG‐drugs, a sizeable fraction of patients develop anti‐PEG antibodies (APA), leading to reduced efficacy and potential adverse events. We surveyed physicians from sever...

Descripción completa

Detalles Bibliográficos
Autores principales: McSweeney, Morgan D., Versfeld, Zina C., Carpenter, Delesha M., Lai, Samuel K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866984/
https://www.ncbi.nlm.nih.gov/pubmed/29383836
http://dx.doi.org/10.1111/cts.12537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866984/
https://www.ncbi.nlm.nih.gov/pubmed/29383836
http://dx.doi.org/10.1111/cts.12537

Ejemplares similares